Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
A very good place to experience a lot and move at a fast pace; however, often frustrating due to lack of focus on main objectives for the company.
Quelle est la meilleure partie de votre programme de rémunération?
It is competitive with industry standards
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Open minded to alternative approaches and collaborative across functions
Quelles sont les meilleures choses à propos de votre équipe?
Very collaborative and talented group
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Coworkers are friendly and talented
Qu’est-ce qui ne va pas et comment cela peut-il être amélioré?
Inconsistent goals and constantly shifting priorities by the day. Management rushes too much to push multiple objectives forward which results in work that often must be repeated or adjusted. More focus is needed to focus on a clear set of objectives.
Other Employee Reviews for Karyopharm Therapeutics
×